Jonathan Mermin, MD, MPH, is a Rear Admiral in the USPHS and the Director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) at CDC, where he oversees programmatic, research, and policy activities, and an annual budget of $1 billion.
From 2009 to 2013, he was Director of the Division of HIV/AIDS Prevention (DHAP), leading the agencies’ domestic HIV prevention activities. He also served as the Director of CDC-Kenya for three years and the Director of CDC-Uganda for seven years.
Dr. Mermin is a graduate of Harvard College and Stanford University School of Medicine. He received his MPH from Emory University, and was an internal medicine resident at San Francisco General Hospital and a preventive medicine resident at the California Department of Health Services and CDC.
Eugene McCray, MD, is the Director of the Division of HIV/AIDS Prevention (DHAP) in CDC’s NCHHSTP. Dr. McCray began his career at CDC as an Epidemic Intelligence Service Officer, and was instrumental in CDC’s early efforts of the HIV/AIDS epidemic.
Dr. McCray previously held senior positions in CDC’s Division of TB Elimination and the Coordinating Office for Global Health, including Director of CDC’s Global AIDS Program. Dr. McCray has directed and developed epidemiological, programmatic, and research activities, and led collaboration across CDC, with other US government agencies, multilateral and international agencies, and Ministries of Health.
Dr. McCray completed his clinical training in internal medicine at North Carolina Memorial Hospital, University of North Carolina Chapel Hill and completed an Infectious Diseases Fellowship at University of Washington Medical Center, Seattle, Washington. He has authored or co-authored more than 70 scholarly articles and recognition for his scientific and public health contributions include the US Public Health Service’s highest honor award, the PHS Distinguished Service Medal, and CDC’s William C. Watson Medal of Excellence award.
Janet C. Cleveland, MS, is the Deputy Director for Prevention Programs in the Division of HIV/AIDS Prevention (DHAP) in NCHHSTP at CDC. Ms. Cleveland has held numerous leadership positions at CDC in DHAP, providing counsel on national programs and policies to develop and sustain community capacity for planning and implementing HIV prevention programs, and providing priority prevention services to affected communities
Ms. Cleveland has also served in senior positions in CDC’s Office of the Director, NCHHSTP, and the National Immunization Program. Prior to these positions, she developed, implemented, and evaluated CDC HIV and STD prevention education programs, materials, and training curricula.
Before joining CDC, Ms. Cleveland focused on HIV and STD prevention in the public health sector, and developed programs and policies to increase the participation of persons of color and women in AIDS clinical trials and research. She also has worked in state/local public health leadership positions. She has served as a co-author on various publications related to HIV prevention. Ms. Cleveland received her Bachelor of Science and Masters of Science in Health Education, with a focus in Community Health, from the University of Southern Mississippi. She has also completed Harvard University’s Women of Color in Public Health Leadership Institute.
Irene Hall, PhD, MPH, is Deputy Director for Surveillance, Epidemiology and Laboratory Science (SEL) in the Division of HIV/AIDS Prevention (DHAP). In this role, she oversees CDC’s HIV surveillance, epidemiologic and laboratory research activities.
Dr. Hall joined CDC in 1991. She held a leadership position in CDC’s Division of Cancer Prevention and Control before joining DHAP in 2002. Dr. Hall served in leadership roles for the HIV Incidence and Case Surveillance Branch before becoming Deputy Director for SEL in 2016. Dr. Hall has regularly published on a variety of HIV related topics, including HIV surveillance and analytic methodologies as well as the epidemiology of HIV. Her research interests have included trends in HIV among gay and bisexual men, the impact of HIV on urban and rural communities, survival, and indicators of HIV care. She has led CDC’s work in producing new estimates of HIV incidence in the United States.
Dr. Hall received her MPH and PhD in Epidemiology from Yale University. She is a Fellow of the American College of Epidemiology (ACE).
David Purcell, JD, PhD, is the Deputy Director for Behavioral and Social Science of the Division of HIV/AIDS Prevention (DHAP), at CDC’s NCHHSTP. He oversees four branches that focus on behavioral research, communications, program evaluation, and statistics and cost modeling. From 2007 to 2012, he was chief of the Prevention Research Branch in DHAP where he was responsible for overseeing the development of CDC funding announcements for HIV/AIDS demonstration projects.
Prior to starting work as a behavioral scientist at CDC in 1996, Dr. Purcell was a practicing attorney in Atlanta. He was on the founding boards of two community-based organizations, Positive Impact, designed to provide free mental health services to low income persons infected with and affected by HIV, and YouthPride, an organization to support the needs of LGBT youth in Atlanta.
Dr. Purcell is the author of over 125 scientific publications. He received a BA in psychology and economics from Vanderbilt University, a JD from the University of Michigan Law School, and a PhD in clinical psychology from Emory University.
Paul Gaist, PhD, MPH serves as a health scientist administrator, as well as the lead for behavioral and social sciences research (BSSR) and the co-lead for the “Reduce the Incidence of HIV” priority area, at the National Institutes of Health (NIH) Office of AIDS Research (OAR). In these roles, he oversees, shapes, and accounts for the BSSR aspects of the NIH HIV/AIDS Research Program. In addition to BSSR, his efforts encompass other key areas such as HIV prevention, implementation science, portfolio analysis, and other overarching program and science planning.
Prior to joining OAR, after working on a national research study on theories of depression conducted through the National Institute of Mental Health (NIMH), Dr. Gaist joined the NIMH intramural research scientific staff as the program director of the Seasonal Affective Disorders Research Program. From there, he moved to the Alcohol, Drug Abuse, and Mental Health Administration, an HHS agency that was the precursor to what is now the Substance Abuse and Mental Health Services Administration (SAMHSA). There he served as a senior science analyst in the Administrator’s Office and then as the deputy director for the HIV/AIDS program for the Agency. He then joined OAR in the Office of the Director at NIH.
Dr. Gaist earned bachelor’s degrees in psychology and physiology from the University of California, Berkeley. He received his PhD in behavioral science research and health education and an MPH in health policy and management from the Johns Hopkins Bloomberg School of Public Health.
Gabriel Maldonado, MBA, is the Founder and Chief Executive Officer of TruEvolution serving the LGBTQ community in Riverside and San Bernardino Counties, CA. As a Ryan White-supported agency, TruEvolution engages in national advocacy efforts as well as direct-services.
Originally from Compton, California, Mr. Maldonado has been a community organizer for nearly fifteen years. He initially worked with the Los Angeles Police Department’s Teen Community Police Advisory Board to address gang violence resulting from racial tensions, poverty, and police distrust in the community. It was his own experiences with poverty, domestic violence, and social isolation that drove a passion for social justice. Mr. Maldonado works to combat the social determinants, including poverty, access to healthcare, stigma, housing insecurity, and mental health disparities, which exacerbate rates of HIV/AIDS in LGBTQ communities of color.
Mr. Maldonado served on the Presidential Advisory Council on HIV/AIDS, where he was appointed as Co-Chair of the Disparities Committee. In addition, he works on global health issues as a member of the AIDS Healthcare Foundation’s Board of Directors, supporting the work of the Foundation’s initiatives surrounding youth, women and young girls, Black gay men, and LGBT communities in developing countries around the world.
Mr. Maldonado has an MBA in Global Business, and currently serves on the Advisory Boards for Janssen Therapeutics, Merck & Co., and the National Advisory Board for Viiv Healthcare.
Johanne Morne, MS, currently serves as Director of the New York State Department of Health AIDS Institute, and coordinates the State’s overall response to the HIV epidemic. Her professional and clinical experience is in public health and behavioral health, particularly within communities of color.
The AIDS Institute develops and evaluates programs for HIV, hepatitis, sexually transmitted diseases (STDs) prevention, drug user health, and Lesbian, Gay, Bisexual, and Transgender (LGBT) health and human services. Other activities include disease surveillance, opioid overdose prevention, non-HIV LGBT services, and oversight of clinical standards and health education.
Ms. Morne advanced deliberations related to Undetectable=Untransmittable, which led for New York to be the first state to sign on to the U=U consensus statement. Ms. Morne currently serves as a board member of the National Alliance of State and Territorial AIDS Directors (NASTAD). Ms. Morne is also an honoree in the 2017 POZ 100: Celebrating Women.
Prior to joining the State Health Department, Ms. Morne served as quality manager of psychiatry and HIV services at a Designated AIDS Center hospital and director of community-based HIV services at a federally qualified health center. Her degrees include a BA in Psychology, a BS in Social Work and a MS in Education and Counseling.
Michael J. Mugavero, MD, MHSc, is Professor of Medicine at the University of Alabama at Birmingham (UAB) and Project Director of the University of Alabama (UAB 1917) Clinic Cohort. His research focuses on the influence of socio-behavioral and contextual factors across the HIV care continuum including testing, engagement and retention in medical care, antiretroviral medication adherence, and ultimately, health outcomes.
Dr. Mugavero has published on conceptual frameworks, measurement and methodological considerations, implications of care engagement for health outcomes, and intervention development and evaluation. He provides particular expertise in the area of retention in care, serving as Interventions Section Chair for Guidelines on Entry and Retention in Care, Co-Leader of an AETC NRC Working Group that developed an Engagement in Care Toolkit, and site PI for the CDC/HRSA Retention in Care Study that generated two evidence-informed interventions.
Dr. Mugavero serves as Associate Director for the Center for Outcomes Effectiveness Research and Education, Co-Director of the Center for AIDS Research, and Director of UAB’s Clinical Core facility. He received his medical degree from Vanderbilt University School of Medicine and completed his internal medicine residency from UAB and an infectious diseases fellowship at Duke University.
Judith Steinberg, MD, is the Chief Medical Officer (CMO) at the Bureau of Primary Health Care (BPHC), part of the Health Resources and Services Administration (HRSA). As CMO, Dr. Steinberg steers and oversees the clinical focus and content of the health center program and its policies, along with ensuring the Bureau’s activities are aligned with the U.S. Department of Health and Human Services’ strategic public health priorities. Dr. Steinberg is also a clinical associate professor of family medicine and community health at the University of Massachusetts (UMass) Medical School.
In her former role at UMass Medical School, Dr. Steinberg provided clinical expertise and leadership in the design and implementation of health care reform initiatives involving new care delivery and payment models, such as the patient-centered medical home, behavioral health and primary care integration and accountable care organizations. Dr. Steinberg has more than 25 years of experience in primary care and infectious disease including caring for patients and serving as medical director at community health centers in Boston.
Dr. Steinberg earned her medical degree from the University of Texas, and completed a residency in internal medicine at Beth Israel Hospital in Boston, as well as an infectious disease fellowship at Beth Israel/Brigham and Women’s Hospitals in Boston. She was a fellow in minority health policy and received a Master of Public Health from Harvard University.